VelosBio jumps on megaround bandwagon with $137M series B

With its $137 million series B round Wednesday, VelosBio became the 50th biotech this year to raise a venture round topping the $100 million mark (see

Read the full 265 word article

How to gain access

Continue reading with a
two-week free trial.